Portage Biotech presents preclinical data for PORT-7
Portage Biotech (PRTG) presented new preclinical data for PORT-7, a selective Adenosine A2B receptor inhibitor. The new data demonstrate both ...
360Dx13d
Epredia Bolsters Cancer Testing Menu With High-Throughput Digital Pathology System
The precision cancer business of PHC Holdings anticipates an increase in cancer cases and is expanding its digital pathology and immunohistochemistry instrument lineup.
Original paper18d
Assessment of the status of DNA mismatch repair proteins by immunohistochemistry. Proposal for evaluation with two antibodies
Instituto Nacional De Cancerologia De Mèxico, Mexico City, Mexico AFINES program, Medicine Faculty, National Autonomous University of Mexico (UNAM), Coyoacan, Mexico City, Mexico Hospital Angeles ...
The Guardian Nigeria18d
Pharma, tech firms unveil initiative to support 5,000 breast cancer patients
Swiss pharma giant, Roche, in collaboration with Oncopadi Technologies, has launched a Breast Cancer Access Navigation and Testing Programme ...
AllAfrica.com19d
Nigerian Govt Partners Roche, Oncopadi Technologies to Improve Breast Cancer Care
The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 ...